Coforge Limited has finalized a $550 million loan facility to support its strategic investments in the Encora business. Simultaneously, the company has completed its previously announced preferential equity share allotment and expanded its leadership team by appointing two new non-executive directors. These moves are part of the firm’s broader plan to bolster its financial flexibility and support long-term growth following its recent international acquisitions.
Strategic Financing for Growth
Coforge has successfully secured a loan facility of up to $550 million from a consortium of global lenders, including JPMorgan Chase Bank, Bank of America, Citibank, HSBC, and BNP Paribas. This facility, which comes with a 3-year tenor, is earmarked for primary investments into the equity shares of Encora US Holdco, Inc. and Encora Holdings Limited. The loan is secured by a first-ranking pari passu charge over the company’s current and movable fixed assets.
Preferential Share Allotment
As part of its ongoing integration strategy, the company has completed the allotment of 9,37,96,508 fully paid-up equity shares on a preferential basis. The shares were issued at INR 1,815.91 per share, resulting in an aggregate consideration of approximately INR 17,032.60 crore. The allottees include Encora Holdco Limited and AI Altius Parent (Cayman) Limited, successfully closing the share swap arrangement initiated in late 2025.
Leadership Expansion
Strengthening its governance, the board has approved the appointment of Shweta Jalan and Atin Hirachand Jain as Additional Directors (Non-Executive). Both appointees bring extensive experience from Advent Private Equity, covering technology and healthcare investment landscapes. These appointments, effective as of April 23, 2026, remain subject to shareholder approval and are intended to provide strategic oversight as the company navigates its next phase of expansion.
Source: BSE
